官方网站:http://pubget.com/journal/0392-2936/european-journal-of-gynaecological-oncology
投稿网址:
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0392-2936%5BISSN%5D
欧洲妇科肿瘤学杂志-EJGO(ISSN 0392-2936)发表了女性生殖器癌和相关学科、预防、早期检测、流行病学、病理学、诊断、管理以及妇科肿瘤学学会全球会议记录等领域的原始同行评审工作,最好是简要报告。ejgo包含在ISI期刊主列表、哥白尼国际索引、科学引文索引扩展、当前内容-临床医学、科学网、索引medicus/medline、embase excerpta medica、pubmed、medsci、pubget、genamics journalsek、sciencescape、unbound medicine、pubfacts.com中。目的与范围EJGO致力于发表“杰出专家系列”中的编辑文章和原创研究论文、案例报告、给编辑的信、书评以及时事通讯。该杂志成立于1980年,是世界上第二份妇科肿瘤超专科杂志。其目的是在妇科医生、肿瘤学家、放射治疗师、外科医生、化学治疗师、病理学家、流行病学家等之间以跨学科的方式传播科学、临床和实践进展以及女性肿瘤疾病方面的知识。
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY – EJGO (ISSN 0392-2936) publishes original peer reviewed work, preferably brief reports, in the fields of female genital cancers and related subjects, prevention, early detection, epidemiology, pathology, diagnosis, management, and also proceedings of Gynaecologic Oncology Society global meetings. EJGO is covered by ISI Journal Master List, Index Copernicus International, Science Citation Index Expanded, Current Contents - Clinical Medicine, Web of Science, Index Medicus/MEDLINE, EMBASE Excerpta Medica, PubMed, MedSci, Pubget, Genamics JournalSeek, Sciencescape, Unbound Medicine, PubFacts.com.AIMS AND SCOPEEJGO is dedicated to publishing editorial articles in the “Distinguished Expert Series” and original research papers, case reports, letters to the Editor, book reviews, and newsletters. The Journal was founded in 1980 – the second gynaecologic oncology hyperspecialization Journal in the world. Its aim is the diffusion of scientific, clinical and practical progress, and knowledge in female neoplastic diseases in an interdisciplinary approach among gynaecologists, oncologists, radiotherapists, surgeons, chemotherapists, pathologists, epidemiologists, and so on.
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学 | 4区 4区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q4 | OBSTETRICS & GYNECOLOGY | Q4 | 0.255 |
ONCOLOGY | Q4 |
* 请认真填写需求信息,学术顾问24小时内与您取得联系。